Diane L. Crombie - Concepedia

Concepedia

Author

Diane L. Crombie

Ligand Pharmaceuticals (United States)

Also Known As

DIANE L. CROMBIE, Diane Crombie, Diane L. Crombie

18

Publications

1.2K

Citations

10

H-Index

33

Concepts

All Affiliations

Ligand Pharmaceuticals (United States)University of California San Diego

DL

About

Diane L. Crombie is an author at Ligand Pharmaceuticals (United States) specializing in medicine, pharmacology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	868
2	Health Sciences	4	4	811
3	Biochemistry	3	3	198
4	Diabetes	3	3	727
5	Natural Sciences	1	1	42

Diane L. Crombie

×

10

Publications

1.2K

Citations

10

H-Index

	Year	Citations
Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists Ranjan Mukherjee, Peter J. Davies, Diane L. Crombie, Nature ObesityMetabolic SyndromeInsulin SignalingMedicinePhysiology	1997	610
Differential Effects of Rexinoids and Thiazolidinediones on Metabolic Gene Expression in Diabetic Rodents Harleen Singh Ahuja, Sha Liu, Diane L. Crombie, Molecular Pharmacology	2001	113
Metabolic Effects of Rexinoids: Tissue-Specific Regulation of Lipoprotein Lipase Activity Peter J. Davies, Stacey A. Berry, Gregory L. Shipley, Molecular Pharmacology	2001	89
Negative feedback regulation of the ileal bile acid transport system in rodents Jan Lillienau, Diane L. Crombie, J Raya Muñóz, Gastroenterology Molecular PhysiologyDigestive PhysiologyBiochemistryHealth SciencesBiliary Tract	1993	84
The Rexinoid LG100754 Is a Novel RXR:PPARγ Agonist and Decreases Glucose Levels<i>in Vivo</i> Rosemary M. Cesario, Kay Klausing, Haleh Razzaghi, Molecular Endocrinology PharmacotherapyInsulin ReceptorRexinoid Lg100754Insulin SignalingPparγ Agonist	2001	72
Biological Characterization of a Heterodimer-Selective Retinoid X Receptor Modulator: Potential Benefits for the Treatment of Type 2 Diabetes Mark D. Leibowitz, Robert Ardecky, Marcus F. Boehm, Endocrinology	2005	69
Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the zucker diabetic fatty rat Sharon Dana, Patricia A. Hoener, James Bilakovics, Metabolism Metabolic SyndromePeripheral Gene ExpressionLiver PhysiologyPhysiologyDiabetes	2001	45
Discovery and Preliminary SAR Studies of a Novel, Nonsteroidal Progesterone Receptor Antagonist Pharmacophore Charlotte L. F. Pooley, James P. Edwards, Mark E. Goldman, Journal of Medicinal Chemistry Medicinal ChemistryHpr Modulatory ActivityBiochemistryPharmacological StudyMedicine	1998	42
Synthesis and Biological Activity of Novel Nonsteroidal Progesterone Receptor Antagonists Based on Cyclocymopol Monomethyl Ether Lawrence G. Hamann, Luc J. Farmer, Michael G. Johnson, Journal of Medicinal Chemistry	1996	35
Acute Effects of Topical Methyl Tert–Butyl Ether or Ethyl Propionate on Gallbladder Histology in Animals: A Comparison of Two Solvents for Contact Dissolution of Cholesterol Gallstones Oliver Esch, John C. Spinosa, Ronald L. Hamilton, Hepatology GastroenterologySurgeryDigestive TractGallbladder HistologyOrganic Solvents	1992	15

Page 1